Roberto Oliveri, MD, PhD

Roberto Oliveri, MD, PhD has a diverse and extensive work experience in the medical field. Roberto is currently the Head of Medical Translational Development at Nykode Therapeutics since May 2022. In this role, they serve as the medical project lead for therapeutic vaccine VB10. 16, focusing on oncology, infectious diseases, and immune tolerance. Roberto is also involved in leading various trials and personalized vaccine programs.

Prior to this, Oliveri worked as a Medical Director at Genmab from April 2018 to April 2022. Here, they played a key role in designing and conducting clinical research for pivotal cancer studies. Roberto acted as the study lead and represented the program or disease area. Roberto also contributed to the overall medical strategy of clinical development programs and provided medical advice on potential new projects.

Oliveri also served as a Senior International Medical Manager and an International Medical Manager at Novo Nordisk from January 2016 to March 2018. Roberto'sresponsibilities included preparing and reviewing documents, interacting with investigators and health authorities, and disseminating results.

Earlier, they worked as a Medical Advisor at Novartis Oncology in 2015 and as a Medical Doctor specializing in medical immunology, cell therapy, and transfusion medicine at Rigshospitalet from 2008 to 2014. In this role, they gained clinical experience in cell therapy, transplantation immunology, and pediatric cancer diagnosis. Roberto also conducted research on stem cell trials and ATMP registration.

Oliveri's early career included research and medical roles at Rigshospitalet from 2002 to 2008, where they focused on human embryonic stem cell lines, epigenetic reprogramming, and clinical biochemistry. Roberto also worked as a Medical Doctor in gastroenterology, cardiology, family medicine at Bispebjerg Hospital and in gynecology and obstetrics at Herlev Hospital in 2000.

Roberto Oliveri, MD, PhD, completed their education in a chronological order as follows:

In 2000, they obtained a Medical Doctor (MD) degree from Københavns Universitet - University of Copenhagen.

In 2008, they pursued their studies further and earned a Doctor of Philosophy (PhD) degree from Københavns Universitet - University of Copenhagen.

In 2014, Roberto acquired a Board-certification in medical immunology and cell therapy from Rigshospitalet.

In the same year, they also completed a Strategic Research Management program from Copenhagen Business School.

Additionally, Roberto obtained certification in Project Management (PRINCE2) from Implement A/S, although the exact month and year are not provided.

Overall, Roberto Oliveri's educational background demonstrates their achievements in both medical and research fields, with additional expertise in project management through their PRINCE2 certification.